X

Xenon Pharmaceuticals
D

XENE

39.250
USD
0.22
(0.56%)
مغلق
حجم التداول
0
الربح لكل سهم
-4
العائد الربحي
-
P/E
-14
حجم السوق
2,992,404,379
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    BIIB
    BIIB
    1.810
    (1.28%)
    142.750 USD
    B
    BLUE
    -0.31000
    (-3.79%)
    7.86000 USD
    GILD
    GILD
    0.070
    (0.08%)
    93.020 USD
    N
    NBIX
    0.840
    (0.58%)
    146.750 USD
    R
    RARE
    1.650
    (4.00%)
    42.950 USD
    S
    SRPT
    -0.920
    (-0.79%)
    116.020 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    X
    XNCR
    0.250
    (1.22%)
    20.690 USD
    المزيد
الأخبار
المقالات

العنوان: Xenon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.